Long-term outcomes of salvage radiotherapy for PSA-recurrent prostate cancer: Validation of the stephenson nomogram

World Journal of Urology

Volumn 28, Issue 6, 2010, Pages 741-744

  Hugen, Cory M ^a   Polcari, Anthony J ^a   Quek, Marcus L ^a   Garza, Richard P ^a   Fitzgerald, Mary P ^a   Flanigan, Robert C ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biochemical recurrence; Nomogram; Prostate neoplasm; Salvage radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ALGORITHM; ARTICLE; BLOOD; HUMAN; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MALE; METHODOLOGY; MIDDLE AGED; NOMOGRAM; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY; RADIOTHERAPY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SALVAGE THERAPY; STATISTICAL MODEL; TREATMENT OUTCOME; TUMOR RECURRENCE; VALIDATION STUDY;

AGED; ALGORITHMS; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 78049469337     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-010-0559-x     Document Type: Article

References (17)

1. Pound CR, Partin AW, Eisenberger MA et al (1999) Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281: 1591-1597.
2. Katz MS, Zelefsky MJ, Venkatraman ES et al (2003) Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 21: 483-489.
3. Freedland SJ, Humphreys EB, Mangold LA et al (2007) Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality. J Clin Oncol 25: 1765-1771.
4. Laventis AK, Shariat SF, Kattan MW et al (2001) Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 19: 1030-1039.
5. Song DY, Thompson TL, Ramakrishnan V et al (2002) Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology 60: 281-287.
6. Simmons MN, Stephenson AJ, Klein EA (2007) Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol 51: 1175-1184.
7. Freedland SJ, Humphreys EB, Mangold LA et al (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 294: 433-439.
8. Stephenson AJ, Scardino PT, Kattan MW et al (2007) Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 25: 2035-2041.
9. Cornfield J (1962) Joint dependence of risk of coronary heart disease on serum cholesterol and systolic blood pressure: a discriminant function analysis. Fed Proc 21: 58-61.
10. Stephenson AJ, Shariat SF, Zelefsky MJ et al (2004) Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 291: 1325-1332.
11. Han M, Partin AW, Zahurak M et al (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169: 517-523.
12. Sartor CI, Strawderman MH, Lin XH et al (1997) Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy. Int J Radiat Oncol Biol Phys 38: 941-947.
13. Partin AW, Pearson JD, Landis PK et al (1994) Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology 43: 649-659.
14. D'Amico AV, Chen MH, Roehl KA et al (2005) Identifying patients at risk for significant versus clinically insignificant postoperative prostate-specific antigen failure. J Clin Oncol 23: 4975-4979.
15. Trock BJ, Han M, Freedland SJ et al (2008) Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 299: 2760-2769.
16. Cher ML, Bianco FJ Jr, Lam JS et al (1998) Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol 160: 1387-1391.
17. Moul JW (2000) Prostate specific antigen only progression of prostate cancer. J Urol 163: 1632-1642.